Talquetamab-tgvs injection orders must be signed by a Hematology/Oncology Attending Physician
Inpatient use of talquetamab-tgvs injection is restricted to patients who meet one of the following criteria:
Initiation/new-start treatment for relapsed/refractory multiple myeloma
Re-initiation of treatment in patients with relapsed/refractory multiple myeloma who have experienced a treatment delay that requires re-initiation with step-up doses
All other use is restricted to outpatient encounters or clinic use only (ie, no inpatient use)
Add Formweb to your mobile device
UNC Health
System Formulary Restriction:
Talquetamab-tgvs injection orders must be signed by a Hematology/Oncology Attending Physician
Inpatient use of talquetamab-tgvs injection is restricted to patients who meet one of the following criteria:
All other use is restricted to outpatient encounters or clinic use only (ie, no inpatient use)